Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy
暂无分享,去创建一个
N. Okiyama | T. Misu | N. Suzuki | M. Aoki | T. Shijo | R. Izumi | Yuri Okada | Y. Ichimura | Satoshi Watanabe | Tatsuhiko Hosaka | Risa Konishi | N. Hatchome | M. Aoki | R. Konishi